about
Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.Variation in critical care services across North America and Western Europe.Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management.Nurses' attitudes and knowledge regarding organ and tissue donation and transplantation in a provincial hospital: A descriptive and multivariate analysis.Impact of harmful use of alcohol on the sedation of critical patients on mechanical ventilation: A multicentre prospective, observational study in 8 Spanish intensive care units.Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute respiratory distress syndrome.Brain death organ donation potential and life support therapy limitation in neurocritical patients.Impact of training on intensive care providers' attitudes and knowledge regarding limitation of life-support treatment and organ donation after circulatory death.Endotracheal tube intraluminal diameter narrowing after mechanical ventilation: use of acoustic reflectometry.Medical Students for Tissue Procurement, a 10-Year Experience in a Large University Hospital: An Exportable Model?Successful liver transplantation despite donor-transmitted ESBL-producing Klebsiella pneumoniae infection: Case report and review of the literature.Successful multiple organ donation after donor brain death due to Actinomyces israelii meningitis.Procalcitonin accurately predicts lung transplant adults with low risk of pulmonary graft dysfunction and intensive care mortality.Related factors to semi-recumbent position compliance and pressure ulcers in patients with invasive mechanical ventilation: An observational study (CAPCRI study).Midazolam and 2% propofol in long-term sedation of traumatized critically ill patients: efficacy and safety comparison.Incidence, etiology, and outcome of nosocomial pneumonia in ICU patients requiring percutaneous tracheotomy for mechanical ventilation.[Cyclic rotation of antibiotics. Is all that glitters gold?].Impact of an on-line educational program on life support treatment limitation (lstl) and potentiality for donation after controlled cardiac death (cdcd) of critically ill patients in 11 hospitals of catalonia.Effect of Antibiotic Diversity on Ventilator-Associated Pneumonia Caused by ESKAPE OrganismsManagement of ventilator-associated pneumonia in a multidisciplinary intensive care unit: does trauma make a difference?Impact of diversity of antibiotic use on the development of antimicrobial resistanceRespuesta de los autoresFactors related to limitation of life support within 48 h of intensive care unit admission: A multicenter studyFactores relacionados con el cumplimiento de la posición semiincorporada en el paciente con ventilación mecánica según los profesionales: cuestionario CAPCRI-QImpacto de la fibrinólisis en el ictus isquémico sobre la mejoría clínica y la calidad de vida. Implementación del código ictus en el hospital de referencia del Camp de TarragonaRecomendaciones en la sedo-analgesia del paciente crítico[Depression and use of antidepressants in the critical patient][Prolonged sedation in Intensive Care Units][Use of neuromuscular blockers in the critical patient]Nueva estrategia de actuación en los accesos venosos centrales y su influencia en bacteriemias[Recommendations of the Analgesia and Sedation Group of SEMICYUK for sedation/analgesia and neuromuscular blocking in the critical patient. Presentation]
P50
Q30400544-58CB661B-25DD-4CE6-8053-77322566FE9FQ34819861-64A7AA16-3814-41E8-B76A-C3F6D13CAC6DQ37988346-954C042B-DE90-4251-9EAD-E3EB0191E878Q38717994-70D8DBF0-FBEA-448B-85C3-7BA2187604E7Q40344140-B70656DB-481F-4294-98DC-840E5B12D2AEQ40506695-EF623428-ED22-4003-8211-3C0D06C107B8Q45028122-24FBF9E1-2400-412E-B973-A9E41F7E4700Q47214636-BAAF52D1-1EAA-4085-A97E-3CDFE36A80FAQ47884875-4278B2B1-815A-4FA8-BFC3-DA4FF5BEAED3Q47975445-0D0F0AA6-26EA-423E-877B-9A66C993BB6DQ48152905-C2013024-73D9-4619-ADC3-AC6DBA14A8F3Q48248917-A73B6628-FD38-4866-9EC9-E7E958C1D72BQ50120720-FB2588D1-BADA-4ED9-BB5E-C1408AC74E09Q51256866-11368F59-0504-4282-93C6-1F5799F96034Q51371616-E13E5CC9-3009-4F7D-BA54-A014D0FD7B12Q51639743-85DDA272-F52C-49BA-BE28-58AC94889AD5Q53940938-5236C854-4DC2-47F6-9C83-DFB827D8B808Q54858421-60548F82-BFC0-428E-A4D6-77CD927D4F05Q57237789-3A71BC0E-E1C5-4666-A190-88C7A769E49CQ57237924-475B90CA-D994-45D4-A322-82E72B3A185FQ57237975-4BA067DA-933E-45C5-900C-919B681D0864Q58860083-A5D7568F-31FE-4B1A-9884-99C56A7811C0Q64130584-BFDD1ECD-D3D4-4BA4-88EC-18050290B93CQ64130597-F382C118-82AF-45A6-A9DD-0A28FC44EA5EQ64130602-D48159D0-26C8-4FA4-B522-A4739E5C910BQ64130609-2D21B23F-98B2-4251-AACF-8CEA5D44DB3BQ64130615-B3F7C34F-211E-4FC5-9536-58DB426F965EQ64130619-2CCC8286-2ECE-42FE-A64A-A84898F93808Q64130625-3E9EB4D1-A6DA-4A6C-989F-5D7E90F33AF4Q64130633-1247A44C-2964-4F0C-98D0-0DA057147B27Q81063586-9124319C-70C4-4CD3-B8F8-6343F702D2FD
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alberto Sandiumenge
@ast
Alberto Sandiumenge
@en
Alberto Sandiumenge
@es
Alberto Sandiumenge
@nl
Alberto Sandiumenge
@sl
type
label
Alberto Sandiumenge
@ast
Alberto Sandiumenge
@en
Alberto Sandiumenge
@es
Alberto Sandiumenge
@nl
Alberto Sandiumenge
@sl
prefLabel
Alberto Sandiumenge
@ast
Alberto Sandiumenge
@en
Alberto Sandiumenge
@es
Alberto Sandiumenge
@nl
Alberto Sandiumenge
@sl
P106
P21
P31
P496
0000-0001-8838-3007